Understand the source comparison
SS-31 Anti-Aging Protocol Dosage Timing: Administration Methods Comparison
Once daily (morning only) 6–8 hours Protective effect present <35% of each 24-hour cycle; 16-hour trough with no mitochondrial stabilization Covers morning oxidative peak but misses afternoon cortisol surge and evening metabolic transition Not recommended. Sin
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Once daily (morning only)
- 6–8 hours
- Protective effect present <35% of each 24-hour cycle; 16-hour trough with no mitochondrial stabilization
- Covers morning oxidative peak but misses afternoon cortisol surge and evening metabolic transition
- Not recommended. Single-daily dosing leaves >60% of the circadian cycle unprotected, negating longevity biomarker improvements seen in twice-daily protocols
- Twice daily (8–12 hour spacing)
- 16–18 hours
- Protective effect sustained across >70% of circadian cycle with minimal trough depth
- Aligns with both morning (cortisol) and evening (metabolic) ROS peaks when timed at 7–8 AM and 5–6 PM
- Standard research protocol. Maintains therapeutic plasma levels across diurnal oxidative stress windows; matches timing used in published Phase 2 trials
- Three times daily (every 8 hours)
- 20–22 hours
- Near-continuous cardiolipin protection with overlapping plasma curves
- Covers all circadian oxidative windows but introduces mid-sleep dosing inconvenience
- Theoretically optimal but impractical. Overnight injection requirement (2:00–3:00 AM) creates compliance issues; biomarker improvement vs twice-daily is marginal (<8% in VO2 max studies)
- Pulsed weekly dosing
- <12 hours per week
- Protective effect present <10% of total cycle; no sustained membrane stabilization
- Misses 85–90% of oxidative stress events across the week
- Ineffective. SS-31 does not accumulate in tissue; weekly pulsing results in negligible cardiolipin binding and zero measurable improvement in mitochondrial function biomarkers